Načítá se...
Pioneer of prostate cancer: past, present and the future of FOXA1
Prostate cancer is the most commonly diagnosed non-cutaneous cancers in North American men. While androgen deprivation has remained as the cornerstone of prostate cancer treatment, resistance ensues leading to lethal disease. Forkhead box A1 (FOXA1) encodes a pioneer factor that induces open chromat...
Uloženo v:
| Vydáno v: | Protein Cell |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Higher Education Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7815845/ https://ncbi.nlm.nih.gov/pubmed/32946061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13238-020-00786-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|